Left atrial volume index in patients with seborrheic dermatitis
Methods: Fifty individuals diagnosed with seborrheic dermatitis who presented to the dermatology outpatient clinic were included, alongside a control group of healthy participants (n=30) matched by age and sex. Echocardiographic assessments were carried out for both groups, and the data were recorded using standardized forms.
Results: The left atrial volume index (LAVI) was recorded as 28.3±1.24 in seborrheic dermatitis patients and 26.2±1.47 in the control group, with this difference reaching statistical significance (P<0.001). Similarly, the E/e' ratio was found to be 8.52±0.777 in the patient group and 7.16±0.706 in the control group, demonstrating a statistically significant difference (P<0.001).
Conclusions: The observed increase in LAVI and E/e' ratio among seborrheic dermatitis patients suggests a potential association with an elevated risk of cardiovascular disease and atrial fibrillation. Given these findings, long-term monitoring of individuals with seborrheic dermatitis may be warranted.
1. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185-190.
2. Celik MS, Arpa A. Evaluation of epicardial fat tissue thickness in patients with seborrheic dermatitis. Arch Dermatol Res. 2025;317(1):364. doi: 10.1007/s00403-025-03909-5.
3. Imamoglu B, Hayta SB, Guner R, Akyol M, Ozcelik S. Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis. Arch Med Sci Atheroscler Dis. 2016;1(1):e158-161. doi: 10.5114/amsad.2016.65075.
4. Linder D, Dreiher J, Zampetti A, Sampogna F, Cohen AD. Seborrheic dermatitis and hypertension in adults: a cross-sectional study. J Eur Acad Dermatol Venereol. 2014;28(11):1450-1455. doi: 10.1111/jdv.12310.
5. Tosun M, Yasak Güner R, Akyol M. Investigation of the relationship between inflammatory blood parameters and seborrheic dermatitis. J Cosmet Dermatol. 2022;21(10):5111-5115. doi: 10.1111/jocd.14984.
6. Mangia M, D'Andrea E, Cecchetto A, Beccari R, Mele D, Nistri S. Current and Clinically Relevant Echocardiographic Parameters to Analyze Left Atrial Function. J Cardiovasc Dev Dis. 2024;11(8):241. doi: 10.3390/jcdd11080241.
7. Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol. 2014;63(6):493-505. doi: 10.1016/j.jacc.2013.10.055.
8. Tsang TS, Barnes ME, Gersh BJ, et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol. 2003;42(7):1199-1205. doi: 10.1016/s0735-1097(03)00943-4.
9. Ahmeti A, Bytyçi FS, Bielecka-Dabrowa A, Bytyçi I, Henein MY. Prognostic value of left atrial volume index in acute coronary syndrome: A systematic review and meta-analysis. Clin Physiol Funct Imaging. 2021;41(2):128-135. doi: 10.1111/cpf.12689.
10. Atas H, Kepez A, Bozbay M, et al. Assessment of left atrial volume and function in patients with psoriasis by using real time three-dimensional echocardiography. Wien Klin Wochenschr. 2015;127(21-22):858-863. doi: 10.1007/s00508-015-0817-4.
11. Aksan G, Nar G, Soylu K, et al. Assessment of atrial electromechanical delay and left atrial mechanical functions in patients with psoriasis vulgaris. Echocardiography. 2015;32(4):615-622. doi: 10.1111/echo.12706.
12. Simsek H, Sahin M, Akyol A, et al. Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients. ScientificWorldJournal. 2013;2013:901215. doi: 10.1155/2013/901215.
13. Krajewski PK, Matusiak Ł, Ständer S, Thaçi D, Szepietowski JC, Zirpel H. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study. Int J Dermatol. 2024;63(6):799-805. doi: 10.1111/ijd.17186.
13. Sánchez-Díaz M, Salvador-Rodríguez L, Cuenca-Barrales C, Arias-Santiago S, Molina-Leyva A. Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: A cross-sectional study. J Dermatol. 2022;49(12):1238-1244. doi: 10.1111/1346-8138.16558.
15. Juhl CR, Miller IM, Jemec GB, Kanters JK, Ellervik C. Hidradenitis suppurativa and electrocardiographic changes: a cross-sectional population study. Br J Dermatol. 2018;178(1):222-228. doi: 10.1111/bjd.15778.
16. Mitter SS, Shah SJ, Thomas JD. A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure. J Am Coll Cardiol. 2017;69(11):1451-1464. doi: 10.1016/j.jacc.2016.12.037.
17. Bülbül Şen B, Ekiz Ö, Rifaioğlu EN, et al. Assessment of subclinical left ventricular dysfunction in patients with psoriasis by speckle tracking echocardiography: A Speckle Tracking Study. Int J Dermatol. 2016;55(2):158-164. doi: 10.1111/ijd.12703.
18. Baykal Selçuk L, Şahin M, Aydemir B, Aksu Arıca D, Yaylı S. Effects of interleukin-12/23 inhibitors and interleukin-17 inhibitors on myocardial functions in patients with severe psoriasis. Turkderm-Turk Arch Dermatol Venereol. 2024;58(4):112-116. doi: 10.4274/turkderm.galenos.2024.20737.
19. Mikeladze B, Zhvania N, Nikolaishvili G. E/e' Ratio as a Predictor of In-Hospital Complications and Clinical Outcomes of Acute Myocardial Infarction. Cureus. 2024;16(8):e66795. doi: 10.7759/cureus.66795.
Copyright (c) 2025 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Research Article
- Submitted February 21, 2026
- Published November 3, 2025
- Issue Vol. 11 No. 6 (2025)
- Section Research Article
